RE: POC14 Aug 2021 22:29
I have lost almost all trust in DB and the board.
To me it is clear, now 1.5 months since the anticipated Trading Update - which for the last 5 years has been released in July/August (02 August 2016/ 13 July 2017 / 13 July 2018 / 09 July 2019 / 10 July 2020) - that this company is not speaking so as to avoid telling what ever truth there is to be told. And for me once trust is eroded the relationship turns sour.
Here is where I stand on the issues with GDR, DB and the team:
1) GDR state BC don't announce sales - that's ok, because I didn't invest in BC. But why is Walbrook refusing to respond to queries regarding any shipments post the one to BC (that they RNSd) or any other distributor, yet answering other questions in the same email? Either DB is being silenced via takeover conversations or we have nothing sold (which is hard to believe given other products and their commercial status).
2) DB told me in an email that they can't announce the HCV/ UNICEF agreement until UNICEF give them sign-off. I now believe this is just an excuse to delay any official announcement (for what ever reason you decide) because our product has been listed on the online catalogue for months now and the contracts issued to GDR and others in March is already out in the public domain (listed online) since March - so why do we need further permission?
3) We get Indian ICMR approval and import licence and DB is quicker to degrade our chances than to talk about how they are working with the authorities and distributors there to come to a reasonable conclusion. Remember back in November 2020 and prior, the US and India were our main 2 target markets and now DB is not afraid to say that India may not plan out???? So as a company we don't negotiate, we just accept and let be???
4) In the 360DX article on Jul 13 2021, DB admitted that HCV sales had resumed. Now you tell me how can #WorldHepaptitisDay go by on social media and GDR, nor Walbrook nor any distributor promote/market our product. We just had 3 case studies from Georgia, Cameroon and Thailand released this year (2 of which were with FIND) and we say very little???
5) The EU MoH deal which DB said in Nov 2020 was at an advanced stage - where has this gone? Was this any real deal to be converted? How can we not convert a deal at advanced stages and why haven't we got a reason for this via Half Year results? DB said to me its not dependent on us its the MoH - what a poor excuse for lack of ability to convert a deal with a 'gold-standard' (and proven) test.
Sign In
Follow the stocks
